공캡슐 시장 : 캡슐 유형별, 재료별, 충전 물건 유형별, 캡슐 사이즈별, 판매 채널별, 최종 사용자별 시장 예측(2026-2032년)

The Empty Capsules Market is projected to grow by USD 3.99 billion at a CAGR of 6.01% by 2032.

The empty capsules market sits at the center of oral solid dosage innovation, serving prescription drugs, over-the-counter medicines, clinical trials, and dietary supplements. Demand is supported by the global preference for convenient, taste-masked, accurately dosed, and portable dosage forms.

Growth is being shaped by wider use of gelatin capsules, rapid adoption of vegetarian HPMC capsules, and rising demand for specialty capsules designed for delayed release, moisture-sensitive fills, inhalation, and liquid or semi-solid formulations. For manufacturers and brand owners, capsule performance, regulatory compliance, supply reliability, and clean-label positioning are now core competitive factors.

Transformative Shifts in the Empty Capsules Landscape

The landscape is shifting from commodity capsule supply toward differentiated dosage-form platforms. Pharmaceutical companies increasingly require capsules that support complex APIs, faster development timelines, pediatric and geriatric dosing, and clinical trial blinding. Nutraceutical brands are also moving toward plant-based capsules as consumers scrutinize animal-derived ingredients and label transparency.

Supply chains are becoming more strategic. Gelatin sourcing must address traceability, allergen expectations, and BSE/TSE documentation, while HPMC and pullulan capsules appeal to vegan, halal, kosher, and moisture-sensitive applications. At the same time, automation-ready capsules with tight dimensional consistency are gaining importance as high-speed filling lines expand worldwide.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to improve the economics and quality of capsule production. AI-enabled inspection systems can identify defects such as dents, cracks, color variation, and improper locking with greater consistency than manual checks, supporting higher yield and stronger GMP compliance.

AI is also influencing formulation development. Predictive models help teams assess capsule-shell compatibility, moisture transfer, dissolution behavior, and fill-material stability before scale-up. In procurement and manufacturing, AI supports demand planning, raw-material management, preventive maintenance, and deviation analytics, helping capsule suppliers reduce downtime and improve delivery reliability in regulated markets.

Key Regional Insights Across Global Empty Capsules Demand

Asia-Pacific is a major growth engine for empty capsules due to expanding pharmaceutical manufacturing in China and India, rising supplement consumption, and cost-competitive production capacity. Japan, South Korea, and Australia contribute demand for high-quality capsules aligned with strict regulatory, nutraceutical, and functional food standards, while regional demand is supported by aging populations, higher healthcare access, and broader use of preventive wellness products.

North America remains a high-value market led by the United States and Canada, where FDA-regulated pharmaceutical production, contract development and manufacturing, clinical research activity, and a mature dietary supplement industry support premium capsule demand. Europe is driven by strong GMP expectations, pharmacopeial compliance, vegetarian capsule adoption, and sustainability goals across Germany, France, Italy, Spain, and the United Kingdom.

Latin America, led by Brazil and Mexico, is benefiting from expanding generic drug access, growing self-care markets, and increasing regional production of solid oral dosage forms. The Middle East is increasingly influenced by halal certification, healthcare investment, and pharmaceutical localization programs, while Africa presents long-term opportunities tied to medicine access, local manufacturing initiatives, donor-supported health programs, and rising demand for affordable oral dosage forms.

Key Group Insights for Empty Capsule Market Expansion

ASEAN markets are becoming important for empty capsules as regional pharmaceutical production, supplement manufacturing, and medical tourism expand across countries such as Indonesia, Thailand, Malaysia, Vietnam, and Singapore. The region's diverse consumer base increases demand for halal, vegetarian, and cost-effective capsule formats, while export-oriented production strengthens the need for internationally compliant capsule quality.

The GCC is shaped by healthcare diversification, local pharmaceutical investment, and strong preference for halal-compliant ingredients. The European Union emphasizes regulatory harmonization, pharmacopeial quality, excipient traceability, and sustainability, making it a strong market for traceable gelatin and plant-based capsules.

BRICS economies combine large patient populations, generic medicine demand, and expanding domestic manufacturing, making them central to volume-led capsule demand. G7 countries drive premium innovation, clinical trial use, stringent quality documentation, and advanced capsule technologies, while NATO members overlap significantly with regulated pharmaceutical markets that prioritize supply security, quality assurance, and resilient sourcing.

Key Country Insights Shaping the Empty Capsules Market

The United States leads premium demand through its large pharmaceutical, nutraceutical, and clinical research ecosystem, while Canada emphasizes regulated quality, bilingual labeling requirements, and clean-label supplements. Mexico and Brazil are important Latin American markets where generic medicines, local pharmaceutical production, and consumer health products support rising capsule consumption.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show strong demand for GMP-grade capsules, vegetarian formats, reliable excipient documentation, and compliance with pharmacopeial expectations. Russia remains relevant through domestic pharmaceutical production, essential medicine needs, and import substitution priorities.

China and India are pivotal because they combine large-scale capsule manufacturing with expanding domestic drug and supplement markets, supported by strong roles in generic pharmaceuticals and active ingredient supply chains. Japan and South Korea favor high-specification capsules for quality-sensitive formulations, aging-population healthcare needs, and advanced nutraceutical products, while Australia's supplement sector and strict quality expectations support demand for premium gelatin and HPMC capsules.

Actionable Recommendations for Empty Capsule Industry Leaders

Industry leaders should invest in diversified capsule portfolios that include gelatin, HPMC, pullulan, delayed-release, and liquid-fill compatible capsules. This approach helps serve pharmaceutical, nutraceutical, and specialty formulation customers while reducing exposure to single-material risk.

Manufacturers should strengthen supplier qualification, pharmacopeial testing, allergen controls, halal and kosher certification, and BSE/TSE documentation. Commercial teams should prioritize high-growth applications such as probiotics, personalized nutrition, clinical trials, pediatric dosing, geriatric-friendly formats, and moisture-sensitive APIs. AI-based visual inspection, predictive maintenance, and demand planning should be adopted to improve quality, yield, and service levels.

Research Methodology for the Empty Capsules Analysis

This executive summary is developed through secondary research, market triangulation, and industry validation using publicly available regulatory, pharmacopeial, trade, and industry-level information. The analysis considers pharmaceutical manufacturing trends, dietary supplement demand, material preferences, dosage-form innovation, and regional healthcare dynamics.

Research inputs include regulatory expectations from agencies such as the FDA and EMA, quality principles aligned with GMP and pharmacopeial standards, and observable shifts in capsule materials, filling technologies, supply-chain practices, and end-use demand. Insights are synthesized to provide strategic, decision-ready guidance without relying on unverified claims, unsupported market sizing, market share, or forecasting.

Conclusion: Strategic Outlook for Empty Capsules

The empty capsules market is evolving from a standardized excipient category into a strategic dosage-form enabler. Demand is being reinforced by global growth in oral solid medicines, nutraceuticals, clinical development, and consumer preference for convenient and transparent health products.

Future competitiveness will depend on quality consistency, regulatory readiness, material innovation, plant-based options, supply resilience, and digital manufacturing capabilities. Companies that combine technical capsule expertise with regional market intelligence and AI-enabled operations will be best positioned to capture sustainable growth.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Empty Capsules Market, by Capsule Type

• 7.1. Hard
• 7.2. Soft

8. Empty Capsules Market, by Material

• 8.1. Gelatin
  • 8.1.1. Bovine
  • 8.1.2. Fish
  • 8.1.3. Porcine
  • 8.1.4. Poultry
• 8.2. Hydroxypropyl Methylcellulose
• 8.3. Pullulan
• 8.4. Starch

9. Empty Capsules Market, by Filling Type

• 9.1. Granule
• 9.2. Liquid
• 9.3. Pellet
• 9.4. Powder

10. Empty Capsules Market, by Capsule Size

• 10.1. 0
• 10.2. 00
• 10.3. 000
• 10.4. 00E
• 10.5. 0E
• 10.6. 1
• 10.7. 2
• 10.8. 3
• 10.9. 4
• 10.10. 5

11. Empty Capsules Market, by Sales Channel

• 11.1. Offline
  • 11.1.1. Direct Sale
  • 11.1.2. Distributor Network
• 11.2. Online

12. Empty Capsules Market, by End User

• 12.1. Animal Healthcare
  • 12.1.1. Feed Additives
  • 12.1.2. Veterinary Pharmaceuticals
• 12.2. Cosmetics
• 12.3. Nutraceuticals
  • 12.3.1. Dietary Supplements
  • 12.3.2. Functional Foods
• 12.4. Pharmaceuticals
  • 12.4.1. Over-The-Counter Drugs
  • 12.4.2. Prescription Drugs

13. Empty Capsules Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Empty Capsules Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Empty Capsules Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. ACG
• 17.2. AlfaCaps LLC
• 17.3. Biowell Labs Canada
• 17.4. Bright Caps GmbH.
• 17.5. CapsCanada
• 17.6. CapsulCN International CO., LTD.
• 17.7. Capsule Connection, LLC
• 17.8. Carlson Laboratories, Inc.
• 17.9. Comed Chemicals Limited
• 17.10. Dah Feng Capsule
• 17.11. Erawat Pharma Limited
• 17.12. Farmacapsulas S.A.
• 17.13. Fortcaps Healthcare Ltd. by Kumar organic products Limited
• 17.14. Gelita AG
• 17.15. GoCaps GmbH by DENAVA GmbH
• 17.16. HBI EuroCaps
• 17.17. Healthcaps India Ltd.
• 17.18. Koordination Krafticus GmbH
• 17.19. LFA Machines Oxford LTD.
• 17.20. Lonza Group AG
• 17.21. Mitsubishi Chemical Group Corporation
• 17.22. Natural Capsules Limited
• 17.23. Nectar Lifesciences Ltd.
• 17.24. Qualicaps
• 17.25. Roxlor LLC
• 17.26. SaintyCo
• 17.27. SavoiurCaps Pvt. Ltd.
• 17.28. Shaoxing Kangke Capsule Co., Ltd.
• 17.29. Silvaco A/S
• 17.30. Snail Pharma Industry
• 17.31. Suheung Co., Ltd.
• 17.32. Sunil Healthcare Limited
• 17.33. The Roxlor Group
• 17.34. Thermo Fisher Scientific Inc.
• 17.35. Vitajoy Group USA